ArticleBMC cancer2017

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis.

Laura Zanotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.